{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:52:03Z","timestamp":1785790323047,"version":"3.56.0"},"reference-count":34,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.3892\/mmr.2017.7139","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T06:49:11Z","timestamp":1501656551000},"page":"5023-5030","source":"Crossref","is-referenced-by-count":21,"title":["Oncogenic miR-100-5p is associated with cellular viability, migration and apoptosis in renal cell carcinoma"],"prefix":"10.3892","volume":"16","author":[{"given":"Peijie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canbin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangchao","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqing","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,8,2]]},"reference":[{"key":"key20180108003103_b1-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"key20180108003103_b2-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0033-1363837","article-title":"Epidemiology and staging of renal cell carcinoma","volume":"31","author":"Ridge","year":"2014","journal-title":"Semin Intervent Radiol"},{"key":"key20180108003103_b3-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180108003103_b4-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"10479","DOI":"10.1007\/s13277-014-2343-9","article-title":"Up-regulation of flotillin-2 is associated with renal cell carcinoma progression","volume":"35","author":"Yan","year":"2014","journal-title":"Tumour Biol"},{"key":"key20180108003103_b5-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7257\/1053-816X.2012.32.4.182","article-title":"Renal cell carcinoma: A reappraisal","volume":"32","author":"Patel","year":"2012","journal-title":"Urol Nurs"},{"key":"key20180108003103_b6-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"key20180108003103_b7-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"v58","DOI":"10.1093\/annonc\/mdw328","article-title":"ESMO Guidelines Committee: Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Escudier","year":"2016","journal-title":"Ann Oncol"},{"key":"key20180108003103_b8-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"E398","DOI":"10.5489\/cuaj.1894","article-title":"Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus","volume":"8","author":"Rendon","year":"2014","journal-title":"Can Urol Assoc J"},{"key":"key20180108003103_b9-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJM199609193351207","article-title":"Renal-cell carcinoma","volume":"335","author":"Motzer","year":"1996","journal-title":"N Engl J Med"},{"key":"key20180108003103_b10-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3892\/or.2015.4045","article-title":"Induction of apoptotic cell death by betulin in multidrug-resistant human renal carcinoma cells","volume":"34","author":"Yim","year":"2015","journal-title":"Oncol Rep"},{"key":"key20180108003103_b11-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMra043172","article-title":"Renal-cell carcinoma","volume":"353","author":"Cohen","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180108003103_b12-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4143\/crt.2009.41.2.67","article-title":"Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: A single cancer center experience in Korea","volume":"41","author":"Hong","year":"2009","journal-title":"Cancer Res Treat"},{"key":"key20180108003103_b13-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","article-title":"Origins and Mechanisms of miRNAs and siRNAs","volume":"136","author":"Carthew","year":"2009","journal-title":"Cell"},{"key":"key20180108003103_b14-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrg2936","article-title":"Gene silencing by microRNAs: Contributions of translational repression and mRNA decay","volume":"12","author":"Huntzinger","year":"2011","journal-title":"Nat Rev Genet"},{"key":"key20180108003103_b15-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: Target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"key20180108003103_b16-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay","volume":"11","author":"Krol","year":"2010","journal-title":"Nat Rev Genet"},{"key":"key20180108003103_b17-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ajh.23570","article-title":"Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK\/T-cell lymphoma","volume":"89","author":"Komabayashi","year":"2014","journal-title":"Am J Hematol"},{"key":"key20180108003103_b18-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.med.59.053006.104707","article-title":"MicroRNAs in Cancer","volume":"60","author":"Garzon","year":"2009","journal-title":"Annu Rev Med"},{"key":"key20180108003103_b19-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10555-009-9188-5","article-title":"MicroRNA function in cancer: Oncogene or a tumor suppressor?","volume":"28","author":"Shenouda","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"key20180108003103_b20-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.biocel.2008.09.005","article-title":"DNA methylomes, histone codes and miRNAs: Tying it all together","volume":"41","author":"Guil","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180108003103_b21-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.3892\/or.2016.4701","article-title":"miR-100 suppresses the proliferation and tumor growth of esophageal squamous cancer cells via targeting CXCR7","volume":"35","author":"Zhou","year":"2016","journal-title":"Oncol Rep"},{"key":"key20180108003103_b22-mmr-16-04-5023","first-page":"3391","article-title":"Overexpression of miR-100 inhibits cell proliferation, migration and chemosensitivity in human glioblastoma through FGFR3","volume":"8","author":"Luan","year":"2015","journal-title":"OncoTargets Ther"},{"key":"key20180108003103_b23-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1007\/s13277-015-4342-x","article-title":"MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt\/\u03b2-catenin signaling pathway","volume":"37","author":"Jiang","year":"2016","journal-title":"Tumour Biol"},{"key":"key20180108003103_b24-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.canlet.2015.08.029","article-title":"C\/EBP\u03b1-induced miR-100 expression suppresses tumor metastasis and growth by targeting ZBTB7A in gastric cancer","volume":"369","author":"Shi","year":"2015","journal-title":"Cancer Lett"},{"key":"key20180108003103_b25-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180108003103_b26-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1158\/0008-5472.CAN-09-2552","article-title":"MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer","volume":"69","author":"Bhattacharya","year":"2009","journal-title":"Cancer Res"},{"key":"key20180108003103_b27-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/1541-7786.MCR-10-0344","article-title":"MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E","volume":"9","author":"Ofir","year":"2011","journal-title":"Mol Cancer Res"},{"key":"key20180108003103_b28-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11255-012-0374-y","article-title":"Overexpression of microRNA-100 predicts an unfavorable prognosis in renal cell carcinoma","volume":"45","author":"Wang","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"key20180108003103_b29-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"11650","DOI":"10.1038\/srep11650","article-title":"The role of miR-100 in regulating apoptosis of breast cancer cells","volume":"5","author":"Gong","year":"2015","journal-title":"Sci Rep"},{"key":"key20180108003103_b30-mmr-16-04-5023","first-page":"2403","article-title":"The role and expression of miR-100 and miR-203 profile as prognostic markers in epithelial ovarian cancer","volume":"8","author":"Azizmohammadi","year":"2016","journal-title":"Am J Transl Res"},{"key":"key20180108003103_b31-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"15948","DOI":"10.4238\/2015.December.7.6","article-title":"Prognostic role of microRNA-100 in patients with bladder cancer","volume":"14","author":"Cao","year":"2015","journal-title":"Genet Mol Res"},{"key":"key20180108003103_b32-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12032-014-0235-x","article-title":"Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer","volume":"31","author":"Chen","year":"2014","journal-title":"Med Oncol"},{"key":"key20180108003103_b33-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11010-013-1753-0","article-title":"Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma","volume":"383","author":"Chen","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"key20180108003103_b34-mmr-16-04-5023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","article-title":"microRNAs as oncogenes and tumor suppressors","volume":"302","author":"Zhang","year":"2007","journal-title":"Dev Biol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T23:10:20Z","timestamp":1569971420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.7139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,2]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,8,2]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.3892\/mmr.2017.7139"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.7139","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,2]]}}}